Agilent makes strategic updates to organizational structure

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) today announced it has moved the company's cell analysis division into its diagnostics and genomics group (dgg) as part of a strategy to further strengthen growth opportunities for both organizations. “we believe having the cell analysis team as part of dgg is a natural fit given the markets they serve and the clear linkages to our genomics and diagnostics customers,” said mike mcmullen, agilent president and ceo. “this i.
A Ratings Summary
A Quant Ranking